Gyre Therapeutics, Inc. (GYRE) Operating cash flow 2016–2025
Gyre Therapeutics, Inc. (GYRE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.0MFY2025 · since FY2016: -$18.5M → $1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.0M | +127.7% |
| FY2024 | -$3.6M | -114.1% |
| FY2023 | $25.9M | +142.5% |
| FY2022 | $10.7M | +112.7% |
| FY2021 | -$83.8M | -52.1% |
| FY2020 | -$55.0M | -26.2% |
| FY2019 | -$43.6M | -52.7% |
| FY2018 | -$28.6M | -43.2% |
| FY2017 | -$19.9M | -7.9% |
| FY2016 | -$18.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice